Table 1.
Characteristics of the participants
| CHD patients | Normal controls | |
|---|---|---|
| Waistline, cm | 96.41±6.78* | 83.45±4.58 |
| BMI, kg/m2 | 28.01±2.31* | 24.04±2.46 |
| SBP, mmHg | 157.96±11.73* | 125.02±6.92 |
| DBP, mmHg | 89.07±9.46* | 78.32±6.15 |
| TC, mmol/L | 5.14±1.17* | 4.43±0.89 |
| HDL-C, mmol/L | 1.31±0.34 | 1.45±0.67 |
| LDL-C, mmol/L | 2.73±1.18* | 2.14±0.59 |
| TG, mmol/L | 1.97±0.99* | 1.33±0.77 |
| FBG, mmol/L | 6.34±0.67* | 5.18±0.52 |
| ASP, µg/L | 5.97±1.33* | 4.89±1.13 |
| C3, µg/ml | 707.6±215.7* | 589.4±115.6 |
Abbreviations: BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure; TC, total cholesterol; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; TG, total triglyceride; FBG, fasting blood glucose; ASP, acylation-stimulating protein. Note: Compared with the control group;
*
P < 0.05.